Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Understanding hair growth involves complex interactions between molecules and could help treat hair disorders.

Male pattern baldness involves genetics, hormones, and needs better treatments.

New research suggests that skin cell renewal may not require a special type of cell previously thought to be essential.

Laser device increases hair density, safe for treating hair loss in men and women.

Androgens, like testosterone, are crucial for early testicular descent in rats.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Finasteride effectively treats baldness but may cause sexual side effects.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Pregnancy increases certain GABA_A receptors in rat brains, influenced by steroid levels.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Skin development in mammals is controlled by key proteins and signals from underlying cells, involving stem cells for maintenance and repair.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.